Search
Feed aggregator
Prostate Drugs May Find New Use in Reducing Risk of Dementia: Study
Prostate Drugs May Find New Use in Reducing Risk of Dementia: Study 6/20/2024
BIOSECURE’s Surprise Absence, the $100+ Billion Future Weight-Loss Market, DIA and More
BIOSECURE’s Surprise Absence, the $100+ Billion Future Weight-Loss Market, DIA and More 6/18/2024
Zentalis Hit With FDA Partial Clinical Hold on Cancer Studies After Patient Deaths
Zentalis Hit With FDA Partial Clinical Hold on Cancer Studies After Patient Deaths 6/18/2024
AstraZeneca’s Truqap Flops in Phase III Triple-Negative Breast Cancer Trial
AstraZeneca’s Truqap Flops in Phase III Triple-Negative Breast Cancer Trial 6/18/2024
Merck Wins FDA Approval for First Pneumococcal Vaccine Designed for Adults
Merck Wins FDA Approval for First Pneumococcal Vaccine Designed for Adults 6/18/2024
GSK Reignites Blenrep Blockbuster Aspirations With Data from Phase III Studies
GSK Reignites Blenrep Blockbuster Aspirations With Data from Phase III Studies 6/18/2024
Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies
Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies 6/18/2024
Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up
Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up 6/18/2024
FDA Slaps BioNTech-MediLink ADC With Partial Clinical Hold Due to ‘Significant Risk of Illness’
FDA Slaps BioNTech-MediLink ADC With Partial Clinical Hold Due to ‘Significant Risk of Illness’ 6/17/2024
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures 6/17/2024
Gilead’s Magrolimab Ineffective, Linked to Increase Risk of Death in MDS Patients
Gilead’s Magrolimab Ineffective, Linked to Increase Risk of Death in MDS Patients 6/17/2024
AstraZeneca’s Imfinzi Gets FDA Approval for Treating Endometrial Cancer
AstraZeneca’s Imfinzi Gets FDA Approval for Treating Endometrial Cancer 6/17/2024
Novo Nordisk CEO Agrees to Testify at Senate Hearing After Sanders’ Subpoena Threat
Novo Nordisk CEO Agrees to Testify at Senate Hearing After Sanders’ Subpoena Threat 6/17/2024
J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win
J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win 6/17/2024
Genetic Therapies Show Early Promise in Treating Obesity
Genetic Therapies Show Early Promise in Treating Obesity 6/17/2024
AI Enables Individualized Cancer Vaccines
AI Enables Individualized Cancer Vaccines 6/17/2024
FDA Action Alert: Merck, BMS, Sarepta and More
FDA Action Alert: Merck, BMS, Sarepta and More 6/17/2024
Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development
Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development 6/17/2024
Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’
Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’ 6/14/2024
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund 6/14/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target